Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide for Late-Life Depression
NCT05007028Completed
- Sponsor
- University Hospital Tours
- Start
- Nov 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nitrous oxide in major depressive disorder (MDD) and treatment-resistant depression (TRD) (2 arms), sponsored by University Hospital Tours. Primary endpoint: Montgomery Asberg Depression Rating Scale at 2 weeks. Started Nov 2021; status: completed.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT05007028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007028.